Literature DB >> 3137625

Increased urinary tribulin output in generalised anxiety disorder.

A Clow1, V Glover, M Sandler, J Tiller.   

Abstract

Urinary output of an endogenous monoamine oxidase inhibitor and benzodiazepine receptor binding inhibitor (tribulin) was raised in a group of patients with generalised anxiety disorder compared with controls. Tribulin levels remained relatively constant in individual patients over the 6-week period of observation, mean values remaining high even after reduction of anxiety following non-drug behaviour therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137625     DOI: 10.1007/bf00181951

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

2.  Distribution of endogenous benzodiazepine receptor ligand-monoamine oxidase inhibitory activity (tribulin) in tissues.

Authors:  I Armando; V Glover; M Sandler
Journal:  Life Sci       Date:  1986-06-02       Impact factor: 5.037

3.  Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors.

Authors:  R Dorow; R Horowski; G Paschelke; M Amin
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

4.  Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitor.

Authors:  V Glover; S K Bhattacharya; M Sandler; S E File
Journal:  Nature       Date:  1981-07-23       Impact factor: 49.962

5.  New endogenous benzodiazepine receptor ligand in human urine: identity with endogenous monoamine oxidase inhibitor?

Authors:  A Clow; V Glover; I Armando; M Sandler
Journal:  Life Sci       Date:  1983-08-22       Impact factor: 5.037

6.  Raised endogenous monoamine oxidase inhibitor output in postwithdrawal alcoholics: effects of L-dopa and ethanol.

Authors:  S K Bhattacharya; V Glover; M Sandler; A Clow; A Topham; M Bernadt; R Murray
Journal:  Biol Psychiatry       Date:  1982-07       Impact factor: 13.382

7.  A monoamine oxidase inhibitor in human urine.

Authors:  V Glover; M A Reveley; M Sandler
Journal:  Biochem Pharmacol       Date:  1980-02       Impact factor: 5.858

8.  Purification and characterization of tribulin, and endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor binding.

Authors:  J D Elsworth; D Dewar; V Glover; B L Goodwin; A Clow; M Sandler
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

9.  Urinary catecholamine metabolite and tribulin output during lactate infusion.

Authors:  A Clow; V Glover; M W Weg; P L Walker; D V Sheehan; D B Carr; M Sandler
Journal:  Br J Psychiatry       Date:  1988-01       Impact factor: 9.319

10.  A benzodiazepine receptor-mediated model of anxiety. Studies in nonhuman primates and clinical implications.

Authors:  T R Insel; P T Ninan; J Aloi; D C Jimerson; P Skolnick; S M Paul
Journal:  Arch Gen Psychiatry       Date:  1984-08
View more
  4 in total

1.  Urinary output of endogenous monoamine oxidase inhibitor and isatin during acute migraine attacks.

Authors:  J Jarman; A Przyborowska; V Glover; J Halket; P T Davies; F C Rose; M Sandler
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Repeated (isolation) stress increases tribulin-like activity in the rat.

Authors:  I Armando; A P Lemoine; M Ferrini; E T Segura; M Barontini
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

3.  The stress-induced reduction in monoamine oxidase (MAO) A activity is reversed by benzodiazepines: role of peripheral benzodiazepine receptors.

Authors:  I Armando; A P Lemoine; E T Segura; M B Barontini
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046

4.  Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson's disease induced by the Japanese encephalitis virus.

Authors:  M Minami; N Hamaue; M Hirafuji; H Saito; T Hiroshige; A Ogata; K Tashiro; S H Parvez
Journal:  J Neural Transm Suppl       Date:  2006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.